The Immunotherapy of Cancer (ITOC) Forum addresses regulatory issues concerning new immunotherapies, hosts workshops, provides education around immunotherapy, and hosts the annual Immunotherapy of Cancer Conference (ITOC).
- The conference, which is the largest immunotherapy meeting in Europe, includes plenary symposium, poster sessions, satellite symposium and an exhibition. The meeting is accredited by the European Council for Continuing Medical Education (EACCME). View more about the next annual conference on http://itoc-conference.eu/
- The ITOC Education workshop on cancer immunotherapy presented by leading faculty in cancer immunotherapy, is designed for clinical oncologists, clinical scientists from industry, regulatory scientists, nurses, patient advocates, students and the entire medical team involved in treating cancer patients with immunotherapy. The course provides a greater understanding of cancer immunotherapies, their therapeutic effectiveness and the appropriate selection and management of cancer patients. The format will be a one-day programme, hosted at cancer meetings throughout the year. Discover more and join one course on http://itoc-conference.eu/itoc-education
- The forum workshops on immunotherapies:
For general information, contact CDDF secretariat:
Cancer Drug Development Forum – CDDF Headquarters
Avenue E. Mounier 83 – B-1200 Brussels, Belgium
Tel: +32 2 775 02 15